From: β-blockers after myocardial infarction and 1-year clinical outcome – a retrospective study
No-β-group N = 141 (Mean ± SD) or Mean (%) | β-group N = 206 (Mean ± SD) or Mean (%) | P-value | |
---|---|---|---|
Background information, risk factors | |||
Age | 64.7 ± 10.3 | 64.1 ± 10 | 0.57 |
Men | 99 (70.2) | 142 (68.9) | 0.81 |
> 74 years | 28 (19.9) | 35 (17.0) | 0.57 |
Smoker | 40 (28.4) | 78 (37.9) | 0.08 |
Hypertension | 59 (41.8) | 108 (52.4) | 0.06 |
Diabetes Mellitus | 31 (22.0) | 50 (24.3) | 0.70 |
Heart failure | 7 (5.0) | 12 (5.8) | 0.81 |
Chronic obstructive pulmonary disease | 8 (5.7) | 15 (7.3) | 0.66 |
Asthma | 9 (6.4) | 9 (4.4) | 0.46 |
Previous MI | 19 (13.5) | 39 (18.9) | 0.19 |
Previous PCI | 16 (11.3) | 38 (18.4) | 0.10 |
Previous CABG | 12 (8.5) | 22 (10.7) | 0.58 |
Systolic blood pressure at admission ±SD | 145.3 ± 24.3 | 152.4 ± 25.7 | 0.02 |
Heart rate at admission | 71.6 ± 15.2 | 82.7 ± 19.3 | < 0.001* |
Diagnosis | |||
NSTEMI | 89 (63.1) | 120 (58.3) | 0.37 |
STEMI | 52 (36.9) | 86 (41.7) | 0.37 |
Coronary treatment during hospital stay | |||
PCI | 111 (78.7) | 170 (82.5) | 0.40 |
CABG | 3 (2.1) | 10 (4.9) | 0.25 |
Discharge | |||
Systolic blood pressure ± SD | 134.2 ± 18.3 | 129.9 ± 18.1 | 0.02 |
Heart rate ± SD | 67.2 ± 11.01 | 67.9 ± 12.12 | 0.88 |
Ejection fraction < 50% | 28 (21.4)3 | 70 (35.4)4 | 0.01 |
Medical treatment at discharge | |||
ACE-I | 73 (51.8) | 149 (72.3) | < 0.001* |
A2-I | 20 14.2) | (15) | 0.88 |
ADP-I | 133 (94.3) | 194 (94.2) | > 0.99 |
Statins | 137 (97.2) | 205 (99.5) | 0.16 |
Aspirin | 136 (96.5) | 187 (90.8) | 0.05 |
Oral anticoagulant | 8 (5.7) | 19 (9.2) | 0.31 |
Long-acting nitrates | 10 (7.1) | 19 (9.2) | 0.56 |
Calcium antagonists | 33 (23.4) | 29 (14.1) | 0.03 |
Diuretics | 20 (14.2) | 40 19.4) | 0.25 |